Incannex Healthcare Stock Forum

$Incannex Healthcare (IXHL.US)$
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2025
Stonegate Capital Partners has updated its coverage on Incannex Healthcare Inc. (NASDAQ: IXHL) for Q1 2025. The company reported research and development costs of $2.9M, marking a $0.3M increase from Q1 2024. IXHL recovered 28.0% of these costs through an R&D tax incentive of $0.8M, with expectations of normalization around 43.5%.
The company has completed dosing for its Phase 2/3 FDA trial ...

$Incannex Healthcare (IXHL.US)$
Incannex Healthcare Announces Strategic Financing for up to $60 Million with Arena Investors

$Incannex Healthcare (IXHL.US)$ Should be getting a quarterly soon. Hoping it will have strategic updates included, at the very least. Think the CEO has been on a holiday since the redomicile 🦗🦗🦗

$Incannex Healthcare (IXHL.US)$ Super low volume climb! But climb is the key word here, especially with most of the market bleeding out! Hehehe

$Incannex Healthcare (IXHL.US)$ Reuters· 4 mins ago
Incannex Healthcare Inc - FDA Approves Phase 2 Clinical Trial for Incannex

$Incannex Healthcare (IXHL.US)$ Reuters· 1 min ago
Dosing Completed in 115 Participant Bioavailability/Bioequivalence

$Incannex Healthcare (IXHL.US)$ Incannex Healthcare Commences Dosing In Phase 2/3 Clinical Trial Assessing IHL-42X In Obstructive Sleep Apnea

$Incannex Healthcare (IXHL.US)$
Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea